Loading clinical trials...
Loading clinical trials...
This study evaluates the efficacy and safety of coenzyme Q10 supplementation as adjunctive therapy in patients with drug-resistant epilepsy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Cheng-Kung University Hospital
NCT06608966 · Epilepsy in Children, Executive Dysfunction
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT06059157 · Drug Resistant Epilepsy
NCT07605858 · Patients With Drug-resistant Focal Epilepsy, SEEG as Part of Presurgical Evaluation
NCT06701084 · Neonatal Epilepsy, Infantile Epilepsy
National Cheng Kung University Hospital
Tainan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions